Regeneron

Regeneron's Arthritis Drug Fails COVID-19 Trial
Regeneron's Arthritis Drug Fails COVID-19 Trial
Motley Fool
Regeneron
Kevazara
COVID-19
pandemic
clinical trials
Flag link:
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
BioSpace
pharma industry
biotech
pandemic
COVID-19
hirings
AGC Biologics
Grail
Grifols
CRISPR Therapeutics
Sana Biotechnology
Point
Sanofi
Medpharm
Regeneron
Flag link:
Regeneron’s Billionaire Cofounder Criticized After ‘All Lives Matter’ Graduation Speech
Regeneron’s Billionaire Cofounder Criticized After ‘All Lives Matter’ Graduation Speech
Forbes
Regeneron
George Yancopoulos
racial diversity
Flag link:
Kiniksa preps BLA as Regeneron drug cruises to a PhIII win — shares soar
Kiniksa preps BLA as Regeneron drug cruises to a PhIII win — shares soar
Endpoints
Kiniksa Pharmaceuticals
Regeneron
Arcalyst
pericarditis
clinical trials
Flag link:
Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug
Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug
MedCity News
Regeneron
Eylea
Massachusetts
kickbacks
macular degeneration
Flag link:
Over a decade ago, a disastrous trial killed research on a potential immunotherapy. Can a Regeneron bispecific revive it?
Over a decade ago, a disastrous trial killed research on a potential immunotherapy. Can a Regeneron bispecific revive it?
Endpoints
immunotherapy
Regeneron
clinical trials
bispecific antibodies
Flag link:
Merck treads on Sanofi, Regeneron's turf with Keytruda's latest skin cancer OK
Merck treads on Sanofi, Regeneron's turf with Keytruda's latest skin cancer OK
Fierce Pharma
Merck
Keytruda
FDA
squamous cell carcinoma
Sanofi
Regeneron
Libtayo
Flag link:
Regeneron vows to fight DOJ lawsuit alleging charity donations were Eylea kickbacks
Regeneron vows to fight DOJ lawsuit alleging charity donations were Eylea kickbacks
Fierce Pharma
Regeneron
DOJ
Eylea
kickbacks
charity
Flag link:
Sanofi, Regeneron Win China Approval For Dupixent Dermatitis Drug
Sanofi, Regeneron Win China Approval For Dupixent Dermatitis Drug
Yahoo/SmarterAnalyst
Sanofi
Regeneron
China
Dupixent
atopic dermatitis
Flag link:
AAD 2020 – Leo’s eczema wildcard proves tame
AAD 2020 – Leo’s eczema wildcard proves tame
EP Vantage
LEO Pharma
Sanofi
Regeneron
eczema
atopic dermatitis
AAD
tralokinumab
Flag link:
Regeneron brings first COVID-19 antibody 'cocktail' into human tests
Regeneron brings first COVID-19 antibody 'cocktail' into human tests
BioPharma Dive
Regeneron
clinical trials
antibodies
COVID-19
Flag link:
AbbVie to pay Genmab $750M upfront to form bispecific R&D pact
AbbVie to pay Genmab $750M upfront to form bispecific R&D pact
Fierce Biotech
AbbVie
bispecific antibodies
cancer
Genmab
Regeneron
epcoritamab
Flag link:
Regeneron joins $100M round for DNAnexus and its cloud-computing DNA software
Regeneron joins $100M round for DNAnexus and its cloud-computing DNA software
Endpoints
DNAnexus
DNA
Stanford
Regeneron
Flag link:
Where Will Regeneron Be in 5 Years?
Where Will Regeneron Be in 5 Years?
Motley Fool
Regeneron
Flag link:
Regeneron to expand development deal with Intellia Therapeutics
Regeneron to expand development deal with Intellia Therapeutics
Marketwatch
Regeneron
Intellia Therapeutics
hemophilia A
hemophilia B
CRISPR
drug development
Flag link:
What Sanofi Might Buy With Its Regeneron Windfall
What Sanofi Might Buy With Its Regeneron Windfall
Barron's
Sanofi
Regeneron
M&A
gene therapy
Ultragenyx
Bluebird Bio
Flag link:
Sanofi and Regeneron's Dupixent Scores Another Approval for Dermatitis, This Time in Kids
Sanofi and Regeneron's Dupixent Scores Another Approval for Dermatitis, This Time in Kids
BioSpace
Sanofi
Regeneron
Dupixent
atopic dermatitis
pediatric
Flag link:
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Endpoints
Dupixent
Sanofi
Regeneron
esosinophilic esophagitis
EoE
clinical trials
Flag link:
Sanofi to Sell Regeneron Stake Worth About $13 Billion
Sanofi to Sell Regeneron Stake Worth About $13 Billion
Yahoo/Bloomberg
Sanofi
Regeneron
Flag link:
Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies
Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies
Fierce Pharma
Regeneron
COVID-19
Kevzara
Pharma CEOs
drug development
vaccines
pandemic
Len Schleifer
Flag link:

Pages